Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Equity (2016 - 2025)

Historic Return on Equity for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Q3 2025 value amounting to 0.46%.

  • Ironwood Pharmaceuticals' Return on Equity fell 11800.0% to 0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46%, marking a year-over-year decrease of 11800.0%. This contributed to the annual value of 0.32% for FY2024, which is 79000.0% up from last year.
  • Ironwood Pharmaceuticals' Return on Equity amounted to 0.46% in Q3 2025, which was down 11800.0% from 0.29% recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Return on Equity registered a high of 3.87% during Q1 2024, and its lowest value of 5.25% during Q2 2023.
  • In the last 5 years, Ironwood Pharmaceuticals' Return on Equity had a median value of 0.67% in 2024 and averaged 0.64%.
  • Its Return on Equity has fluctuated over the past 5 years, first crashed by -55800bps in 2023, then skyrocketed by 59200bps in 2024.
  • Ironwood Pharmaceuticals' Return on Equity (Quarter) stood at 0.89% in 2021, then tumbled by -68bps to 0.28% in 2022, then skyrocketed by 1230bps to 3.74% in 2023, then tumbled by -109bps to 0.34% in 2024, then tumbled by -36bps to 0.46% in 2025.
  • Its Return on Equity was 0.46% in Q3 2025, compared to 0.29% in Q2 2025 and 0.22% in Q1 2025.